Journal
NATURE MEDICINE
Volume 11, Issue 11, Pages 1188-1196Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm1307
Keywords
-
Funding
- NCI NIH HHS [R01 CA090764, CA90764] Funding Source: Medline
- NHLBI NIH HHS [HL071625, R01 HL071625] Funding Source: Medline
- NIDDK NIH HHS [R01 DK060933, DK060933] Funding Source: Medline
Ask authors/readers for more resources
Akt kinases control essential cellular functions, including proliferation, apoptosis, metabolism and transcription, and have been proposed as promising targets for treatment of angiogenesis-dependent pathologies, such as cancer and ischemic injury. But their precise roles in neovascularization remain elusive. Here we show that Akt1 is the predominant isoform in vascular cells and describe the unexpected consequences of Akt1 knockout on vascular integrity and pathological angiogenesis. Angiogenic responses in three distinct in vivo models were enhanced in Akt1(-/-) mice; these enhanced responses were associated with impairment of blood vessel maturation and increased vascular permeability. Although impaired vascular maturation in Akt1(-/-) mice may be attributed to reduced activation of endothelial nitric oxide synthase ( eNOS), the major phenotypic changes in vascular permeability and angiogenesis were linked to reduced expression of two endogenous vascular regulators, thrombospondins 1 ( TSP-1) and 2 ( TSP-2). Re-expression of TSP-1 and TSP-2 in mice transplanted with wild-type bone marrow corrected the angiogenic abnormalities in Akt1(-/-) mice. These findings establish a crucial role of an Akt-thrombospondin axis in angiogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available